About the Company
lemaitre vascular is a provider of devices and implants for the treatment of peripheral vascular disease, a condition that affects more than 20 million people worldwide. the company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. the company's diversified product portfolio consists of brand name devices used in arteries and veins outside of the heart. the company is listed on nasdaq.
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $LMAT News
Engaging In Options Activity, George LeMaitre Exercises Options Valued At $266K In LeMaitre Vascular
What Happened: LeMaitre, Chairman and CEO at LeMaitre Vascular, exercised stock options for 14,808 shares of LMAT stock. This information was disclosed in a Form 4 filing with the U.S. Securities and ...
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Q4 2023 Earnings Call Transcript
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Q4 2023 Earnings Call Transcript February 27, 2024 LeMaitre Vascular, Inc. beats earnings expectations. Reported EPS is $0.38, expectations were $0.36.
LeMaitre to Present at the 23rd Annual Needham Virtual Healthcare Conference
LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that JJ Pellegrino, Chief Financial Officer, will present virtually at the 23rd Annual Needham Virtual Healthcare Conference on Wednesday, April ...
LeMaitre Vascular Inc LMAT
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
LeMaitre to Participate at Upcoming Investor Conferences in March
LeMaitre is a provider of devices, implants, and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops ...
Be Sure To Check Out LeMaitre Vascular, Inc. (NASDAQ:LMAT) Before It Goes Ex-Dividend
Readers hoping to buy LeMaitre Vascular, Inc. (NASDAQ:LMAT) for its dividend will need to make their move shortly, as the stock is about to trade ex-dividend. The ex-dividend date is one business day ...
Q4 2023 LeMaitre Vascular Inc Earnings Call
JJ Pellegrino; CFO; LeMaitre Vascular, Inc. George LeMaitre; CEO and Chairman; LeMaitre Vascular, Inc. Dave Roberts; President; LeMaitre Vascular, Inc. Suraj Kalia ...
LMAT LeMaitre Vascular, Inc.
LeMaitre Vascular, Inc. designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide. It offers restoreflow allografts ...
LeMaitre Vascular, Inc. (LMAT) Q4 2023 Earnings Call Transcript
Welcome to the LeMaitre Vascular Q4 2023 Financial Results Conference Call. As a reminder, today’s call is being recorded. At this time, I would like to turn the conference over to Mr. J.J ...
LeMaitre Vascular Inc LMAT
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Q4 2023 Earnings Call Transcript
LeMaitre Vascular, Inc. beats earnings expectations. Reported EPS is $0.38, expectations were $0.36. LeMaitre Vascular, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end ...
Lemaitre Vascular Inc
Analysts say these cheap stocks have plenty of upside.
Loading the latest forecasts...